Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs
Filed in archive Biotech Hubs and Facilities , Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on March 22, 2007

. "This new investment in GSK's research and development facility will enhance our drug discovery capabilities in Singapore. Our goal is to identify a clinical development candidate by the end of 2007 and we are on track to achieving that," director Paul Chapman was quoted as saying in a statement.
The new laboratory opened Tuesday.
Source: International Herald Tribune
Permalink: Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs
Tags:
biotech
investment
biotech+investment
cognitive+disorder
alzheimer
schizophrenia
drug+discovery
drug
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/59223

Mr Wong
